Dublin, May 01, 2020 (GLOBE NEWSWIRE) -- The "Insulin Delivery Device Market Report: Trends, Forecast, and Competitive Analysis" report has been added to ResearchAndMarkets.com's offering.
The future of the insulin delivery device market looks promising with opportunities in the patients/homecare and hospitals & clinics industries. The global insulin delivery device market is expected to grow with a CAGR of 9% from 2019 to 2024. The major growth drivers for this market are growing geriatric population base, high adoption of sedentary lifestyle and growing awareness of diabetes treatment, technological advancements in insulin delivery devices, and rising awareness of advanced insulin delivery devices.
A report of more than 150 pages is developed to help in your business decisions. To learn the scope of, benefits, companies researched and other details of the insulin delivery device market, then read this report.
The study includes the insulin delivery device market size and forecast for the global insulin delivery device market through 2024, segmented by product type, end user, and region.
Some of the insulin delivery devices companies profiled in this report include Becton Dickinson and Company, Novo Nordisk A/S, Medtronic, Sanofi, ELI Lilly and Company, Ypsomed, Animas, Tandem Diabetes Care, Insulet, and Biocon.
Key Features
Key Questions Answered
Key Topics Covered:
1. Executive Summary
2. Market Background and Classifications
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2013 to 2024
3.1: Macroeconomic Trends and Forecast
3.2: Global Insulin Delivery Device Market: Trends and Forecast
3.3: Global Insulin Delivery Device Market by Product Type
3.3.1: Insulin Syringe
3.3.2: Insulin Pens
3.3.3: Insulin Pumps
3.3.4: Pen Needles
3.3.5: Other Device
3.4: Global Insulin Delivery Device Market by End User
3.4.1: Patients/Homecare
3.4.2: Hospitals & Clinics
4. Market Trends and Forecast Analysis by Region
4.1: Global Insulin Delivery Device Market by Region
4.2: North American Insulin Delivery Device Market
4.2.1: Market by Product Type: Insulin Syringe, Insulin Pens, Insulin Pumps, Pen Needles, and
Other Device
4.2.2: Market by End User: Patients/Homecare and Hospitals & Clinics
4.3: European Insulin Delivery Device Market
4.3.1: Market by Product Type: Insulin Syringe, Insulin Pens, Insulin Pumps, Pen Needles, and
Other Device
4.3.2: Market by End User: Patients/Homecare and Hospitals & Clinics
4.4: APAC Insulin Delivery Device Market
4.4.1: Market by Product Type: Insulin Syringe, Insulin Pens, Insulin Pumps, Pen Needles, and
Other Device
4.4.2: Market by End User: Patients/Homecare and Hospitals & Clinics
4.5: ROW Insulin Delivery Device Market
4.5.1: Market by Product Type: Insulin Syringe, Insulin Pens, Insulin Pumps, Pen Needles, and
Other Device
4.5.2: Market by End User: Patients/Homecare and Hospitals & Clinics
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Market Share Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter's Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for Global Insulin Delivery Device Market by Product Type
6.1.2: Growth Opportunities for Global Insulin Delivery Device Market by End User
6.1.3: Growth Opportunities for Global Insulin Delivery Device Market by Region
6.2: Emerging Trends in Global Insulin Delivery Device Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of Global Insulin Delivery Device Market
6.3.3: Mergers, Acquisitions and Joint Ventures in the Global Insulin Delivery Device Market
7. Company Profiles of Leading Players
7.1: Becton
7.2: Dickinson and Company
7.3: Novo Nordisk A/S
7.4: Medtronic
7.5: Sanofi
7.6: ELI Lilly and Company
7.7: Ypsomed
7.8: Animas
7.9: Tandem Diabetes Care
7.10: Insulet Corporation
7.11: Biocon
For more information about this report visit https://www.researchandmarkets.com/r/bnjwgy
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900